Your browser is no longer supported. Please, upgrade your browser.
ReShape Lifesciences Inc.
Index- P/E- EPS (ttm)-3.06 Insider Own12.70% Shs Outstand17.03M Perf Week-10.60%
Market Cap22.99M Forward P/E- EPS next Y-0.68 Insider Trans-20.12% Shs Float15.42M Perf Month-31.82%
Income-27.80M PEG- EPS next Q-0.17 Inst Own4.60% Short Float3.70% Perf Quarter-55.74%
Sales10.50M P/S2.19 EPS this Y68.30% Inst Trans- Short Ratio1.01 Perf Half Y-67.86%
Book/sh6.60 P/B0.20 EPS next Y77.20% ROA-46.60% Target Price9.12 Perf Year-92.52%
Cash/sh1.71 P/C0.79 EPS next 5Y- ROE-73.10% 52W Range1.43 - 23.40 Perf YTD-17.68%
Dividend- P/FCF- EPS past 5Y30.40% ROI-234.40% 52W High-94.23% Beta-1.09
Dividend %- Quick Ratio3.30 Sales past 5Y-17.00% Gross Margin63.10% 52W Low-5.59% ATR0.12
Employees2 Current Ratio3.60 Sales Q/Q2.90% Oper. Margin- RSI (14)32.18 Volatility6.99% 7.27%
OptionableNo Debt/Eq0.04 EPS Q/Q-143.60% Profit Margin- Rel Volume0.27 Prev Close1.48
ShortableYes LT Debt/Eq0.00 EarningsNov 11 BMO Payout- Avg Volume562.57K Price1.35
Recom2.00 SMA20-18.92% SMA50-28.93% SMA200-69.27% Volume152,407 Change-8.78%
Jan-18-22 08:30AM  
Jan-13-22 08:30AM  
Dec-20-21 08:35AM  
Dec-14-21 08:35AM  
Dec-09-21 12:19PM  
Nov-16-21 08:30AM  
Nov-11-21 08:30AM  
Nov-08-21 08:30AM  
Nov-04-21 08:30AM  
Oct-19-21 08:30AM  
Oct-12-21 08:00AM  
Sep-23-21 08:00AM  
Sep-13-21 08:00AM  
Sep-09-21 08:30AM  
Aug-31-21 08:00AM  
Aug-20-21 12:24PM  
Aug-16-21 08:00AM  
Aug-05-21 08:00AM  
Aug-03-21 08:00AM  
Jul-29-21 08:30AM  
Jul-13-21 08:30AM  
Jul-07-21 08:30AM  
Jul-01-21 08:30AM  
Jun-30-21 08:30AM  
Jun-29-21 09:27AM  
Jun-17-21 08:45AM  
Jun-16-21 07:30AM  
Jun-15-21 12:05PM  
Jun-08-21 07:30AM  
May-24-21 07:30AM  
May-21-21 07:30AM  
May-18-21 07:30AM  
May-17-21 04:05PM  
Mar-10-21 04:30PM  
Mar-08-21 07:00AM  
Jan-22-21 04:46PM  
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bandy Barton P.President and CEODec 02Sale1.8313,42724,571852,015Dec 09 04:22 PM
STANKOVICH THOMASChief Financial OfficerDec 02Sale1.834,3047,863365,707Dec 09 04:17 PM
STANKOVICH THOMASChief Financial OfficerNov 18Buy2.0220,00040,400370,011Nov 18 04:32 PM
Bandy Barton P.President and CEONov 02Sale2.6913,50536,328865,442Nov 16 04:18 PM
STANKOVICH THOMASChief Financial OfficerNov 02Sale2.694,32011,621350,011Nov 16 04:14 PM
STANKOVICH THOMASChief Financial OfficerOct 01Sale2.763,66010,102354,331Oct 12 07:40 PM
Bandy Barton P.President and CEOOct 01Sale2.7712,56534,805878,947Oct 12 07:35 PM
Bandy Barton P.President and CEOSep 10Sale2.89294,494851,088891,512Sep 17 07:07 PM
STANKOVICH THOMASChief Financial OfficerSep 10Sale2.8948,366139,778357,991Sep 17 06:51 PM
GLADNEY DAN WDirectorSep 10Sale2.99200,000598,000283,922Sep 17 06:37 PM
STANKOVICH THOMASChief Financial OfficerAug 30Buy3.4315,00051,43532,613Aug 31 04:31 PM
STANKOVICH THOMASChief Financial OfficerAug 20Buy3.2215,00048,28517,613Aug 24 08:59 AM